This sounds very interesting. Being able to associate specific cancers with pathways worth dampening/shutting down may not just enable new medications but might

This sounds very interesting. Being able to associate specific cancers with pathways worth dampening/shutting down may not just enable new medications but might allow us to leverage existing medications and engineer cocktails of medications for which we already know how they affect the cellular pathways.